The advantage of this study is that FBXL6-driven HCC tumors from Fbxl6 knock-in mice, which may more faithfully reproduce the pathogenesis of HCC initiation and development, were used instead of cell lines for comprehensive proteomics analysis. This evidence concerns the gene FBXL6 and hepatocellular carcinoma.